Taku Naiki

Has grant

associate professor

Nagoya University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Taku Naiki is an associate professor at Nagoya City University in Japan. His research primarily focuses on oncology, specifically in areas such as renal cell carcinoma, prostate cancer, and the efficacy of various treatment modalities. Recent publications include studies on the impact of estimated glomerular filtration rate on survival after targeted therapy and the safety of anamorelin in metastatic urothelial carcinoma. He is actively exploring translational research pathways related to oxidative stress and chemoprevention in prostate cancer.

Recent Grants

Grant: Close

Molecular basis related to the prostate cancer prevention of natural food derived antioxidant flavonoids

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

精巣腫瘍のLSD1による増殖機構解明とその阻害剤による治療法開発のための基礎研究

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

ゲノム不安定性に着目した浸潤性膀胱がん遺伝子治療法の開発

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

拡散強調画像併用MRIで同定しうる膀胱癌の分子プロファイル解明と新規診断法の樹立

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

Development of Elucidation and prophylaxis of prostate cancer onset mechanism that focuses on insulin resistance

Open Date: 2016-04-01

Close Date: 2019-03-31

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Hiroya Hashimoto

Chief

Nagoya University Hospital

JAPAN

View details

Takahiro Yasui

Nagoya University Graduate School of Medicine

JAPAN

View details

Takuya Koie

JAPAN

View details

Keita Nakane

Associate Professor

Gifu University Graduate School of Medicine

JAPAN

View details

Rei Unno

Nagoya University

JAPAN

View details

Atsushi Okada

Associate Professor

Nagoya University Graduate School of Medicine

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Taku Naiki

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (27)

Impact of Estimated Glomerular Filtration Rate and Serum C‐Reactive Protein Level to Overall Survival After Second‐Line Targeted Therapy Following Immuno‐Oncology Combination Therapy for Advanced Renal Cell Carcinoma

Efficacy and safety of anamorelin in patients with metastatic urothelial carcinoma receiving systemic chemotherapy: a randomized controlled study

A case of Page kidney due to an encapsulated perirenal hematoma improved by capsulectomy

Efficacy of prostatectomy using a Retzius‐sparing approach as an additional excision in anal canal carcinoma after brachytherapy for prostate adenocarcinoma

Exploring experimental models of prostate cancer in chemoprevention: Oxidative stress as a key pathway to translational research

The prognostic superiority of second-generation androgen receptor signaling inhibitor in patients with non-metastatic castration-resistant prostate cancer

Preliminary Evidence on Safety and Clinical Efficacy of Luteolin for Patients With Prostate Cancer Under Active Surveillance

Efficacy and Safety of Immuno-Oncology Plus Tyrosine Kinase Inhibitors as Late-Line Combination Therapy for Patients with Advanced Renal Cell Carcinoma

Three‐dimensional computed tomography‐based resection process map for robot‐assisted partial nephrectomy: propensity score matching of a single‐center retrospective study

Urothelial carcinoma occurring in a defunctionalized bladder after urinary diversion due to the bladder exstrophy‐epispadias complex

Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases

Prognostic outcomes in Japanese patients with metastatic castration‐sensitive prostate cancer: Comparative assessments between conventional androgen deprivation therapy (ADT) and ADT with novel androgen receptor signal inhibitor

Experience and Prognostic Analysis with Avelumab Switch Maintenance Treatment in Metastatic Urothelial Carcinoma

C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study

Late relapsing testicle cancer identified with isochromosome 12p (i12p) fluorescence in situ hybridization (FISH) analysis

Successful treatment with enfortumab–vedotin of metastatic signet ring cell cancer expressing nectin‐4 and originating from the bladder

Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence

Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma

Elevated eosinophils proportion as predictor of immune‐related adverse events after ipilimumab and nivolumab treatment of advanced and metastatic renal cell carcinoma

Role of HIKESHI on Hyperthermia for Castration-Resistant Prostate Cancer and Application of a Novel Magnetic Nanoparticle with Carbon Nanohorn for Magnetic Hyperthermia

A rare case of a clear cell carcinoma in a female urethral diverticulum

GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma

Efficacy of Robot-Assisted Ureteroureterostomy in Patients with Complex Ureteral Stricture after Ureteroscopic Lithotripsy

A case of metastatic treatment‐emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy

A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy

Editorial Comment to Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear‐cell renal‐cell carcinoma treated with radical or partial nephrectomy

Efficacy of fosfomycin in preventing infection after endoscopic combined intrarenal surgery in periods of limited supply of first‐ and second‐generation cephalosporins

Collaborators (6)

Hiroya Hashimoto

Takahiro Yasui

Takuya Koie

Keita Nakane

Rei Unno

Atsushi Okada

Make your next move.